19-38412764-C-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_170604.3(RASGRP4):​c.1588G>T​(p.Ala530Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000687 in 1,456,486 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A530T) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

RASGRP4
NM_170604.3 missense

Scores

2
16

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.901

Publications

0 publications found
Variant links:
Genes affected
RASGRP4 (HGNC:18958): (RAS guanyl releasing protein 4) The protein encoded by this gene is a member of the Ras guanyl nucleotide-releasing protein (RasGRP) family of Ras guanine nucleotide exchange factors. It contains a Ras exchange motif, a diacylglycerol-binding domain, and two calcium-binding EF hands. This protein was shown to activate H-Ras in a cation-dependent manner in vitro. Expression of this protein in myeloid cell lines was found to be correlated with elevated level of activated RAS protein, and the RAS activation can be greatly enhanced by phorbol ester treatment, which suggested a role of this protein in diacylglycerol regulated cell signaling pathways. Studies of a mast cell leukemia cell line expressing substantial amounts of abnormal transcripts of this gene indicated that this gene may play an important role in the final stages of mast cell development. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04708749).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_170604.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RASGRP4
NM_170604.3
MANE Select
c.1588G>Tp.Ala530Ser
missense
Exon 13 of 17NP_733749.1Q8TDF6-1
RASGRP4
NM_001146202.2
c.1546G>Tp.Ala516Ser
missense
Exon 13 of 17NP_001139674.1Q8TDF6-2
RASGRP4
NM_001146205.2
c.1486G>Tp.Ala496Ser
missense
Exon 13 of 17NP_001139677.1Q8TDF6-8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RASGRP4
ENST00000615439.5
TSL:1 MANE Select
c.1588G>Tp.Ala530Ser
missense
Exon 13 of 17ENSP00000479844.1Q8TDF6-1
RASGRP4
ENST00000587738.2
TSL:5
c.1588G>Tp.Ala530Ser
missense
Exon 13 of 17ENSP00000465772.1Q8TDF6-1
RASGRP4
ENST00000586305.5
TSL:1
c.1546G>Tp.Ala516Ser
missense
Exon 13 of 17ENSP00000467604.1Q8TDF6-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.87e-7
AC:
1
AN:
1456486
Hom.:
0
Cov.:
32
AF XY:
0.00000138
AC XY:
1
AN XY:
724174
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33380
American (AMR)
AF:
0.0000230
AC:
1
AN:
43452
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25992
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39514
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85552
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53062
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1109566
Other (OTH)
AF:
0.00
AC:
0
AN:
60210
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.055
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
15
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0059
T
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.44
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.79
T
M_CAP
Benign
0.037
D
MetaRNN
Benign
0.047
T
MetaSVM
Benign
-0.47
T
MutationAssessor
Benign
0.070
N
PhyloP100
0.90
PrimateAI
Uncertain
0.48
T
PROVEAN
Benign
0.17
N
REVEL
Benign
0.21
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.018
B
Vest4
0.12
MutPred
0.41
Gain of phosphorylation at A530 (P = 0.0524)
MVP
0.72
MPC
0.29
ClinPred
0.80
D
GERP RS
4.5
Varity_R
0.068
gMVP
0.36
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs766560217; hg19: chr19-38903404; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.